首页> 外国专利> USE OF CDK4/6 INHIBITOR IN COMBINATION WITH EGFR INHIBITOR IN THE PREPARATION OF MEDICAMENT FOR TREATING TUMOR DISEASES

USE OF CDK4/6 INHIBITOR IN COMBINATION WITH EGFR INHIBITOR IN THE PREPARATION OF MEDICAMENT FOR TREATING TUMOR DISEASES

机译:使用CDK4 / 6抑制剂与EGFR抑制剂组合在制备治疗肿瘤疾病的药物中

摘要

Provided in the present invention is a use of CDK4/6 inhibitor in combination with EGFR inhibitor in the preparation of a medicament for treating tumor diseases. In particular, provided in the invention is a use of a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) in combination with a human epidermal growth factor receptor inhibitor (EGFRi) for the preparation of a medicament for preventing or treating tumor diseases.
机译:本发明提供的是CDK4 / 6抑制剂与EGFR抑制剂组合在制备治疗肿瘤疾病的药物中的用途。特别地,本发明提供的是与人表皮生长因子受体抑制剂(EGFRI)组合用于制备用于预防或治疗肿瘤疾病的药物的人表皮生长因子受体抑制剂(EGFRI)的用途。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号